Diabetes Clinical Trials in Arizona

Showing 441-460 of 565 trials

Outpatient Characterization of the Variability of Insulin Secretory Parameters in the Meal Tolerance and the Maximal Stimulation Tests of Subjects With Type 2 Diabetes Mellitus

NCT02346344

A multi-year clinical study to improve tools for measuring the function of insulin-producing beta cells in people with type 2 diabetes mellitus.

Type 2 Diabetes

Foundation for the National Institutes of Health20 participantsStarted Apr 2014

Tempe, Arizona, United States • San Antonio, Texas, United States

COMPLETEDPhase 335 miles

A Phase 3 Study of Ranolazine in Subjects With Type 2 Diabetes Who Are Inadequately Controlled on Metformin Alone

NCT01555164

This is a randomized, double-blind, placebo-controlled, parallel-group, multicenter study to determine the effect of ranolazine when added to metformin on glycemic control in adults with type 2 diabetes mellitus (T2DM) who are inadequately controlled despite current treatment with stable metformin therapy in addition to diet and exercise.

Type 2 Diabetes Mellitus

Gilead Sciences442 participantsStarted Jun 2012

Gulf Shores, Alabama, United States • Little Rock, Alaska, United States • Chandler, Arizona, United States +143 more locations

PreviousPage 23 of 29Next

Outpatient Characterization of the Variability of Insulin Secretory Parameters in the Meal Tolerance and the Maximal Stimulation Tests of Subjects With Type 2 Diabetes Mellitus

A Phase 3 Study of Ranolazine in Subjects With Type 2 Diabetes Who Are Inadequately Controlled on Metformin Alone

Diabetes Trials in Other Cities

Efficacy & Safety of Inhaled Insulin in Type 1 Diabetes

Online Wound Electronic Medical Record (OWEMR) to Decrease Amputations in Diabetics

A Safety and Efficacy Study of Canagliflozin in Older Patients (55 to 80 Years of Age) With Type 2 Diabetes Mellitus

Ranolazine Monotherapy in Subjects With Type 2 Diabetes Mellitus

Efficacy and Safety in Subjects With Type 2 Diabetes Receiving Subcutaneous Basal Insulin and Prandial Inhalation of Technosphere/Insulin Versus Subcutaneous Premixed Insulin Therapy Over a 52-Week Treatment Period and a 4-Week Follow-up

Naturlose (D-Tagatose) Efficacy Evaluation Trial

Safety and Efficacy of LX4211 With Metformin in Type 2 Diabetes Patients With Inadequate Glycemic Control on Metformin

Safety and Efficacy of BGP-15 in Patients With Type 2 Diabetes Mellitus

Clinical Trial Evaluating the Efficacy and Safety of Technosphere® Inhalation Insulin (TI) Inhalation Powder Using the Gen2 Inhaler

Effects of LY2189265 on Glycemic Control in Participants With Type 2 Diabetes

Type 2 Diabetes Evaluation of Ranolazine in Subjects With Chronic Stable Angina

Safety and Efficacy of Technosphere® Insulin Inhalation Powder and Lantus® Compared to Humalog® and Lantus® Over 16-Weeks

Weight Loss Study for People With Type 2 Diabetes

Comparison of Technosphere® Insulin Versus Technosphere Powder (Placebo) in Insulin-Naive Subjects With Type 2 Diabetes Mellitus

Early Feasibility Study 2 of Outpatient Control-to-Range - Testing System Efficacy

Evaluation of the Effect of the InsuPatch Device on Insulin Pharmacokinetics in Clamp Studies

Linagliptin in Combination With Metformin in Treatment Naive Patients With Type 2 Diabetes Mellitus and Insufficient Glycaemic Control

A Study of the Effect of LY2189265 on Two Blood Pressure Drugs

Other Conditions in Arizona